Sign-up for our newsletter
MAIN
Event Calendar
Awardee Reports
ABOUT DIACOMP
Citing DiaComp
Contact
Committees
Institutions
Awardee Reports
Funding Programs
Pilot & Feasibility
Conference Support
Summer Student
Collaborative
External Funding Programs
Publications
Bioinformatics
RESOURCES
Protocols & Methods
Reagents & Resources
Mouse Diet
Breeding Schemes
Validation Criteria
IMPC / KOMP Data
Publications
Bioinformatics
FUNDING PROGRAMS
Pilot & Feasibility
Conference Support
Summer Student
Collaborative
External Funding Programs
CONTACT
PARTICIPANT AREA
Login
Request Account
▹
DiaComp Funded Abstracts
▹
Pilot & Feasibility
▹
Funding Programs
Pilot & Feasibility Program Application Abstract
Urine TCA-Cycle Organic Anions in Diabetic Kidney Disease
Julia Scialla
(Durham, NC)
Pilot & Feasibility Program
Kidney disease occurs in ~25% of patients with diabetes with few strategies to slow progression. Prior work suggests that lower metabolic production of fixed acids in the form of organic anions (OAs) may be a modifiable risk factor for progression of diabetic kidney disease (DKD) and a novel target for secondary prevention. OAs are net produced when the conjugate base of an endogenously produced organic acid is lost from the body in the urine, such as loss of lactate, ketones, and intermediates from the tricarboxylic acid (TCA) cycle. We hypothesize that increased urinary losses of OAs drive favorable changes in kidney energetics in an effort to restore intermediates of the TCA cycle. Specifically, higher OA production will stimulate fatty acid oxidation and branched-chain amino acid (BCAA) metabolism, and inhibit unfavorable pathways that “off-load” excess intermediates, such as gluconeogenesis. The rate at which the kidney reabsorbs and metabolizes OAs is regulated by acid-base status; thus, these changes could be reversed by simple alkali interventions and lead to new treatment strategies for DKD prevention. In this study, we will use samples and data from the prospective Simultaneous Risk Factor Control Using Telehealth to Slow Progression of DKD (STOP-DKD) Study to: (1) characterize OA production in patients with DKD using targeted gas chromatography/mass spectrometry (GC/MS) of 24 hour urine collections to measure TCA-cycle related OAs and selected OAs in plasma (i.e., lactate and ketones); (2) define associations of OA production with dysregulated systemic lipid, glucose, and BCAA metabolism, and (3) generate preliminary evidence of an association of OA production and DKD progression over 12 month follow up. This pilot study will lay the foundation for larger, fully-powered studies evaluating urine TCA cycle-related OAs as modifiable risk factors for DKD progression in the next phase of this research.
No report available yet.
Welcome to the DiaComp Login / Account Request Page.
Email Address:
Password:
Note: Passwords are case-sensitive.
Please save my Email Address on this machine.
Not a member?
If you are a funded DiaComp investigator, a member of an investigator's lab,
or an external advisor to the consortium, please
request an account.
Forgot your password?
Enter your Email Address and
click here.
ERROR!
There was a problem with the page:
User Info
User Confirm
Safari Browser Detected...
We strive to make the DiaComp site compatable with as many browsers as possible, but some of our third party tools don't work with the Safari browser.
In order to explore this site we highly recommend using the most recent versions of the following browsers:
Internet Explorer
Google Chrome
FireFox
Please acknowledge all posters, manuscripts or scientific materials that were generated in part or whole using funds from the Diabetic Complications Consortium(DiaComp) using the following text:
Financial support for this work provided by the NIDDK Diabetic Complications Consortium (RRID:SCR_001415, www.diacomp.org), grants DK076169 and DK115255
Citation text and image have been copied to your clipboard. You may now paste them into your document. Thank you!